KKR Seals $5.7B Integer Holdings Take-Private — Deal Now Definitive, Merger Arb Clock Starts

Event Summary

According to Reuters and Integer Holdings' own press release (via Globe Newswire), KKR & Co. Inc. has signed a definitive agreement to acquire Integer Holdings Corporation (ITGR) in an all-cash deal at $127 per share, implying an enterprise value of approximately $5.7 billion. The transaction was announced August 3, 2026, carries no financing contingency, and is expected to close by year-end subject to shareholder and regulatory approvals. Upon completion, Integer will be delisted from the NYSE and become privately held.

The $127 offer represents a ~51.8% premium to ITGR's April 29, 2026 close (the day before Integer announced its strategic review) and a ~28.8% premium to its 30-day VWAP as of July 31, 2026. This deal is firmly in the M&A Acquisition Wave that has characterized 2026 PE deal flow, building on KKR's recent $7.66B DCC Energy infrastructure buyout.

Integer is a leading medical device contract developer and manufacturer (CDMO), supplying critical components for pacemakers, defibrillators, catheters, and neurostimulation implants to global OEMs.

Leverage Impact Analysis

This is a signed, definitive take-private — the event structure has fundamentally shifted from speculative to merger-arb. The hard reference ceiling is $127 cash.

KKR CFD (live price: $102.16, +4.14% on announcement day): KKR stock CFDs on CoinUnited.io are trading at $102.16 with a session high of $104.00. A trader holding a 50x long KKR CFD entered at $100 would now show a mark-to-market gain of approximately +$2.16 per share × 50 = +$108 per $100 notional — a +108% return on margin. However, the 24h low of $101.05 means intraday whipsaws remain; a 50x position has a liquidation band approximately 2% below entry.

ITGR merger-arb mechanics: With the deal locked at $127 cash, ITGR equity will trade at a discount to $127 — the spread reflecting time value, regulatory risk, and shareholder vote uncertainty. For leveraged CFD traders, ITGR upside is now capped near $127 with limited incremental gain but meaningful downside if the deal breaks. High-leverage longs (>20x) in ITGR face asymmetric risk: upside ~1–3% spread capture versus potential 20–30% downside on deal failure. This is a low-leverage, high-conviction arb setup — not a momentum trade.

The broader global acquisition consolidation wave continues to create sector re-rating opportunities in medtech CDMOs where PE conviction is signaling valuation floor support.

Cross-Market Impact

Healthcare equities: The deal is a sector signal for medtech outsourcing. Boston Scientific and Stryker Corporation — as major OEM customers of Integer-type CDMOs — could see mild positive re-rating on supply chain stability. Edwards Lifesciences Corporation operates in overlapping cardiac device markets. The State Street Health Care Select Sector SPDR ETF offers broad healthcare exposure for traders seeking sector-level positioning rather than single-name arb.

Indices: Healthcare is a defensive S&P 500 weight. A $5.7B take-private removes ITGR from indices, creating minor index rebalancing flows. The NASDAQ 100 Index is less directly affected given ITGR's NYSE listing. Broader cross-sector acquisition repricing dynamics may lift mid-cap healthcare CDMOs on M&A optionality.

Macro/FX/Crypto: No direct linkage. This is a healthcare-specific event with limited macro spillover.

Trading Considerations

KKR stock CFDs trade at $102.16 with a 24h range of $101.05–$104.00 — the deal has been partially priced in. Key resistance is the session high of $104.00; a break higher would confirm sustained institutional accumulation. For the private equity acquisitions theme, monitor whether KKR announces further healthcare deployments near year-end as the Integer close approaches.

For merger-arb in ITGR: watch the deal spread (current ITGR price vs. $127), any FTC/DOJ healthcare manufacturing review signals, and shareholder meeting scheduling. No competing bid has emerged; the board's unanimous approval and absence of a financing contingency reduce deal-break probability materially.

Trade KKR & Co on CoinUnited.io

Trade KKR with up to 1000xx leverage → | Create Free Account